United Therapeutics (UTHR) Cash from Operations (2009 - 2026)
United Therapeutics (UTHR) posted Cash from Operations of 463300000.0 for Q1 2026, up 33.82% sequentially from 346200000.0 in Q4 2025, and little changed YoY from 461200000.0 in Q1 2025.
United Therapeutics (UTHR) Cash from Operations (2009 - 2026) Analysis & Trends
United Therapeutics has reported Cash from Operations for 18 years, with the latest figure at 463300000.0 in Q1 2026.
- Quarterly Cash from Operations changed 0.46% year-over-year to 463300000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1563300000.0 (up 10.73% YoY) and the FY2025 annual result came in at 1561200000.0, up 17.64% from the prior year.
- Cash from Operations rose to 463300000.0 in Q1 2026 per UTHR's latest filing, from 346200000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 562100000.0 in Q3 2025 and troughed at 106300000.0 in Q2 2023.
- A 5-year average of 301888235.29 and a median of 341200000.0 in 2024 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 221.49% in 2022, down 26.58% in 2022.
- Over 5 years, Cash from Operations stood at 128200000.0 in 2022, then advanced by 17.55% to 150700000.0 in 2023, then surged by 126.41% to 341200000.0 in 2024, then grew by 1.47% to 346200000.0 in 2025, then surged by 33.82% to 463300000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 463300000.0, 346200000.0, and 562100000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn | 145.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 313.60 Mn |
| Jun 30, 2026 | 313.60 Mn |
| Mar 31, 2026 | 463.30 Mn |
| Mar 31, 2026 | 463.30 Mn |
| Dec 31, 2025 | 346.20 Mn |
| Dec 31, 2025 | 346.20 Mn |
| Sep 30, 2025 | 562.10 Mn |
| Sep 30, 2025 | 562.10 Mn |
| Jun 30, 2025 | 191.70 Mn |
| Jun 30, 2025 | 191.70 Mn |
| Mar 31, 2025 | 461.20 Mn |
| Mar 31, 2025 | 461.20 Mn |
| Dec 31, 2024 | 341.20 Mn |
| Dec 31, 2024 | 341.20 Mn |
| Sep 30, 2024 | 377.20 Mn |
| Sep 30, 2024 | 377.20 Mn |
| Jun 30, 2024 | 232.20 Mn |
| Jun 30, 2024 | 232.20 Mn |
| Mar 31, 2024 | 376.50 Mn |
| Mar 31, 2024 | 376.50 Mn |